SILVER SPRING, Md., Dec. 4, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration authorized the first diagnostic test for at home collection of patient samples to detect both COVID-19 and influenza A and B (flu). The FDA authorized Quest Diagnostics RC COVID-19 +Flu RT-PCR...
from PR Newswire: https://ift.tt/39JGvHC
No comments:
Post a Comment